Press release
Antisense And RNAi Therapeutics Market to Witness Significant CAGR of +18 % by 2030 | GSK plc, Olix Pharmaceuticals, Inc., Sanofi
The Antisense And RNAi Therapeutics Market research report provides all the information related to the industry. It gives the outlook of the market by giving the authentic data to its client which helps to make essential decisions. It gives an overview of the market which includes its definition, applications and developments and manufacturing technology. This Antisense And RNAi Therapeutics market research report tracks all the recent developments and innovations in the market. It gives the data regarding the obstacles while establishing the business and guides to overcome the upcoming challenges and obstacles.The global Antisense And RNAi Therapeutics Market is expected to grow at a significant CAGR of +18 % by 2030.
Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @: https://www.researchcognizance.com/sample-request/279386?utm_source=openpr.com
Market Overview:
Antisense technology proves valuable for manipulating gene expression, demonstrating success in treating various medical conditions. Companies are leveraging the potential of antisense and RNAi technologies by directing efforts towards advancements in this domain.
Competitive landscape:
This Antisense And RNAi Therapeutics research report throws light on the major market players thriving in the market; it tracks their business strategies, financial status and upcoming products.
Some of the Top companies Influencing in this Market includes:
GSK plc
Olix Pharmaceuticals, Inc.
Sanofi
Alnylam Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma Inc.
Silence Therapeutics
Ionis Pharmaceuticals, Inc
Sarepta Therapeutics
Percheron Therapeutics Limited
Market Scenario:
Firstly, this Antisense And RNAi Therapeutics research report introduces the market by providing the overview which includes definition, applications, product launches, developments, challenges and regions. The market is forecasted to reveal strong development by driven consumption in various markets. An analysis of the current market designs and other basic characteristic is provided in the Antisense And RNAi Therapeutics report.
Regional Coverage:
The region wise coverage of the market is mentioned in the report, mainly focusing on the regions:
• North America
• South America
• Asia and Pacific region
• Middle east and Africa
• Europe
Segmentation Analysis of the market:
The market is segmented on the basis of the type, product, end users, raw materials, etc. the segmentation helps to deliver the precise explanation of the market
Market Segmentation by Technology
RNA Interference
Antisense RNA
Market Segmentation by Application
Genetic Disease
Cancer
Infectious Disease
Neurodegenerative Disorders
Cardiometabolic & Renal Disorders
Ocular Disorders
Respiratory Disorders
Skin Disorders
Market Segmentation by Route of Administration
Intravenous Injections
Intrathecal Injections
Subcutaneous Injections
Other Delivery Methods
Get Up to 30% Discount on the first purchase of this report @: https://www.researchcognizance.com/discount/279386?utm_source=openpr.com
An assessment of the market attractiveness with regard to the competition that new players and products are likely to present to older ones has been provided in the publication. The research report also mentions the innovations, new developments, marketing strategies, branding techniques, and products of the key participants present in the global Antisense And RNAi Therapeutics market. To present a clear vision of the market the competitive landscape has been thoroughly analysed utilizing the value chain analysis. The opportunities and threats present in the future for the key market players have also been emphasized in the publication.
This report aims to provide:
• A qualitative and quantitative analysis of the current trends, dynamics, and estimations from 2024 to 2030.
• The analysis tools such as SWOT analysis, Porter's five force analysis are utilized which explains the potency of the buyers and suppliers to make profit-oriented decisions and strengthen their business.
• The in-depth analysis of the market segmentation helps to identify the prevailing market opportunities.
• In the end, this Antisense And RNAi Therapeutics report helps to save you time and money by delivering unbiased information under one roof.
Table of Contents
Global Antisense And RNAi Therapeutics Market Research Report 2022 - 2029
Chapter 1 Antisense And RNAi Therapeutics Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Antisense And RNAi Therapeutics Market Forecast
Buy Exclusive Report: https://www.researchcognizance.com/checkout/279386/single_user_license
If you have any special requirements, please let us know and we will offer you the report as you want.
Contact Us:
Neil Thomas
116 West 23rd Street 4th Floor New York City, New York 10011
sales@researchcognizance.com
+1 (718) - 509 - 9713
https://www.researchcognizance.com
About Research Cognizance:
Research Cognizance is an India-based market research Company, registered in Pune. Research Cognizance aims to provide meticulously researched insights into the market. We offer high-quality consulting services to our clients and help them understand prevailing market opportunities. Our database presents ample statistics and thoroughly analyzed explanations at an affordable price.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense And RNAi Therapeutics Market to Witness Significant CAGR of +18 % by 2030 | GSK plc, Olix Pharmaceuticals, Inc., Sanofi here
News-ID: 3391804 • Views: …
More Releases from Research Cognizance

Ruminant Methane Reduction Market to Witness Huge Growth by 2031 | Alltech, CH4 …
Ruminant Methane Reduction Market is growing at a Robust CAGR of +7% during the forecast period 2024-2031. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market
Ruminant methane reduction refers to the strategies and practices aimed at decreasing the amount of methane gas produced by ruminant animals such as cows, sheep, and goats. These animals produce methane during the process…

Retail Core Banking Systems Market to Flourish at an Impressive CAGR of 10% by 2 …
Retail core banking systems are the backbone of financial institutions, providing essential services for retail customers. These systems integrate various banking functions, including deposits, withdrawals, transfers, and account management, into a centralized platform. They offer real-time processing capabilities, enabling customers to access their accounts and conduct transactions conveniently. Retail core banking systems also support multiple delivery channels such as branches, ATMs, online banking, and mobile apps, ensuring a seamless customer…

Nitrile Gloves Market Report Covers Future Trends With Research 2024 to 2031 - H …
Nitrile gloves are synthetic rubber gloves widely used in various industries, including healthcare, food handling, and automotive, due to their superior puncture resistance and chemical resistance compared to latex gloves. Made from a compound called nitrile, these gloves offer excellent protection against pathogens and chemicals, making them ideal for medical professionals and laboratory workers. They are latex-free, reducing the risk of allergic reactions, and come in various sizes to ensure…

Precision Medicine Market to Flourish at an Impressive CAGR of 11% by 2031 | Joh …
Precision medicine is a groundbreaking approach to healthcare that tailors medical treatment and interventions to individual characteristics, such as genetic makeup, environment, and lifestyle. By analyzing a patient's unique genetic profile, along with other factors, precision medicine aims to provide more accurate diagnoses and personalized treatment plans. This approach enables healthcare providers to better predict which treatments will be most effective for each patient, minimizing adverse reactions and optimizing outcomes.…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…